Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 64

Related Articles by Review for PubMed (Select 20021000)

1.

Toxicogenomics and cross-species biomarker discovery: applications in drug discovery and safety assessment.

Orr MS.

Toxicol Mech Methods. 2006;16(2-3):79-87. doi: 10.1080/15376520600558317.

PMID:
20021000
2.

The discovery and development of proteomic safety biomarkers for the detection of drug-induced liver toxicity.

Amacher DE.

Toxicol Appl Pharmacol. 2010 May 15;245(1):134-42. doi: 10.1016/j.taap.2010.02.011. Epub 2010 Feb 26. Review.

PMID:
20219512
3.

Toxicology and genetic toxicology in the new era of "toxicogenomics": impact of "-omics" technologies.

Aardema MJ, MacGregor JT.

Mutat Res. 2002 Jan 29;499(1):13-25. Review.

PMID:
11804602
4.

Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.

EFSA GMO Panel Working Group on Animal Feeding Trials.

Food Chem Toxicol. 2008 Mar;46 Suppl 1:S2-70. doi: 10.1016/j.fct.2008.02.008. Epub 2008 Feb 13. Review.

PMID:
18328408
5.

New cancer biomarkers deriving from NCI early detection research.

Verma M, Srivastava S.

Recent Results Cancer Res. 2003;163:72-84; discussion 264-6. Review.

PMID:
12903844
6.

Preclinical pharmacokinetics: an approach towards safer and efficacious drugs.

Singh SS.

Curr Drug Metab. 2006 Feb;7(2):165-82. Review.

PMID:
16472106
7.

Applications of emerging technologies in toxicology and safety assessment.

Reynolds VL.

Int J Toxicol. 2005 May-Jun;24(3):135-7. Review.

PMID:
16040564
8.

Application of genomics in preclinical drug safety evaluation.

Lord PG, Nie A, McMillian M.

Basic Clin Pharmacol Toxicol. 2006 Jun;98(6):537-46. Review.

PMID:
16700814
9.

Toxicogenomics concepts and applications to study hepatic effects of food additives and chemicals.

Stierum R, Heijne W, Kienhuis A, van Ommen B, Groten J.

Toxicol Appl Pharmacol. 2005 Sep 1;207(2 Suppl):179-88. Review.

PMID:
16139318
10.

Informed toxicity assessment in drug discovery: systems-based toxicology.

Mayne JT, Ku WW, Kennedy SP.

Curr Opin Drug Discov Devel. 2006 Jan;9(1):75-83. Review.

PMID:
16445119
11.

Toxicogenomics in drug discovery: from preclinical studies to clinical trials.

Yang Y, Blomme EA, Waring JF.

Chem Biol Interact. 2004 Nov 1;150(1):71-85. Review.

PMID:
15522262
12.

The state-of-the-art in predictive toxicogenomics.

Fielden MR, Kolaja KL.

Curr Opin Drug Discov Devel. 2006 Jan;9(1):84-91. Review.

PMID:
16445120
13.

[Development of antituberculous drugs: current status and future prospects].

Tomioka H, Namba K.

Kekkaku. 2006 Dec;81(12):753-74. Review. Japanese.

PMID:
17240921
14.

Genomics and the search for novel biomarkers in toxicology.

Tugwood JD, Hollins LE, Cockerill MJ.

Biomarkers. 2003 Mar-Apr;8(2):79-92. Review.

PMID:
12775494
15.

Toxicogenomics in predictive toxicology in drug development.

Suter L, Babiss LE, Wheeldon EB.

Chem Biol. 2004 Feb;11(2):161-71. Review.

16.

Risk management frameworks for human health and environmental risks.

Jardine C, Hrudey S, Shortreed J, Craig L, Krewski D, Furgal C, McColl S.

J Toxicol Environ Health B Crit Rev. 2003 Nov-Dec;6(6):569-720. Review.

PMID:
14698953
17.

Alternative strategies in drug development: clinical pharmacological aspects.

Kuhlmann J.

Int J Clin Pharmacol Ther. 1999 Dec;37(12):575-83. Review.

PMID:
10599949
18.

Toxicogenomic approach for assessing toxicant-related disease.

Waters MD, Olden K, Tennant RW.

Mutat Res. 2003 Nov;544(2-3):415-24. Review.

PMID:
14644344
19.

How can toxicogenomics inform risk assessment?

Oberemm A, Onyon L, Gundert-Remy U.

Toxicol Appl Pharmacol. 2005 Sep 1;207(2 Suppl):592-8. Review.

PMID:
15990130
20.

Toxicogenomics: an opportunity to optimise drug development and safety evaluation.

Kramer JA, Kolaja KL.

Expert Opin Drug Saf. 2002 Sep;1(3):275-86. Review.

PMID:
12904143
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk